Vandana Subramanian is a healthcare operator turned early-stage investor, with two decades of experience building and backing science-led ventures across life sciences, genomics, medtech, and digital health. She is currently a Visiting Partner at Antler and is building Caelo Ventures—a London-based Seed+/Series A healthcare fund focused on UK and European innovation. Previously, Vandana was Co-Founder and Chief Business Officer at Sayre Therapeutics (exited), an Accel Partners portfolio company, that scaled to €100M+ in revenue by delivering oncology genomics and specialty therapies globally. She was a...read more